Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 062119/0110 | |
| Pages: | 7 |
| | Recorded: | 12/14/2022 | | |
Attorney Dkt #: | UH4L-001/03US |
Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR'S NAME PREVIOUSLY RECORDED AT REEL: 061648 FRAME: 0733. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . |
|
Total properties:
1
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17849101
|
Filing Dt:
|
06/24/2022
|
Publication #:
|
|
Pub Dt:
|
10/20/2022
| | | | |
Title:
|
TREATING CANCER USING NUCLEIC ACID ENCODING AN ANTI-CD47 BINDING AGENT
|
|
Assignee
|
|
|
C/O KRESTON REEVES LLP |
INNOVATION HOUSE, RAMSGATE ROAD |
SANDWICH, KENT, GREAT BRITAIN CT13 9FF |
|
Correspondence name and address
|
|
COOLEY LLP
|
|
1299 PENNSYLVANIA AVE NW
|
|
SUITE 700
|
|
WASHINGTON, DC 20004
|
Search Results as of:
06/26/2025 07:01 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|